On the contrary, another systematic review and meta-analysis demonstrated that PD-L1 expression enhanced the response to immunotherapy, and HPV status did not affect tumor response or overall survival when patients received anti-PD-L1 therapy [33]. This evidence concerns the gene CD274 and neoplasm.